SCHEMBL3455838

SCHEMBL3455838

CCOC(=O)c1nnn(-c2ccccc2F)c1-c1ccncc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.57
NPSR1 Q6W5P4 2/20 0.57
CYP1A2 P05177 3/20 0.53
CYP2C9 P11712 3/20 0.53
CYP2C19 P33261 3/20 0.53
CYP3A4 P08684 2/20 0.53
MAPK1 P28482 2/20 0.53
POLB P06746 1/20 0.53
HPGD P15428 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
TSHR P16473 2/20 0.52
LMNA P02545 1/20 0.52
GAA P10253 1/20 0.52
CYP19A1 P11511 3/20 0.50
CA1 P00915 2/20 0.50
CA2 P00918 2/20 0.50
CA4 P22748 2/20 0.50
CA9 Q16790 2/20 0.50
TP53 P04637 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13765570 0.87 MEN1 (0.47) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL3457264 0.83 CA1 (0.63) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL25767433 0.82 TP53 (0.67) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL3456117 0.82 ALDH1A1 (0.49) ALDH1A1NPSR1MAPK1POLBMEN1
SCHEMBL25224066 0.82 CA1 (0.72) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL3457023 0.78 SLC5A1 (0.59) ALDH1A1NPSR1TP53ALOX12MAPT
SCHEMBL23771920 0.78 NPSR1 (0.57) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL3455812 0.76 NPSR1 (0.55) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL3455998 0.75 NPSR1 (0.53) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19
SCHEMBL3753122 0.74 ALDH1A1 (0.56) ALDH1A1NPSR1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2250165-B1 TRIAZOLE OXADIAZOLES DERIVATIVES MERCK SERONO SA (CH) 2018-07-25 EP disclosed
EP-2250165-B1 TRIAZOLE OXADIAZOLES DERIVATIVES MERCK SERONO SA (CH) 2018-07-25 EP disclosed
US-8202856-B2 Triazole oxadiazoles derivatives MERCK SERONO SA (CH) 2012-06-19 US disclosed
US-8202856-B2 Triazole oxadiazoles derivatives MERCK SERONO SA (CH) 2012-06-19 US disclosed
US-8202856-B2 Triazole oxadiazoles derivatives MERCK SERONO SA (CH) 2012-06-19 US disclosed
US-20100305092-A1 TRIAZOLE OXADIAZOLES DERIVATIVES MERCK SERONO SA (CH) 2010-12-02 US disclosed
US-20100305092-A1 TRIAZOLE OXADIAZOLES DERIVATIVES MERCK SERONO SA (CH) 2010-12-02 US disclosed
US-20100305092-A1 TRIAZOLE OXADIAZOLES DERIVATIVES MERCK SERONO SA (CH) 2010-12-02 US disclosed
EP-2250165-A1 TRIAZOLE OXADIAZOLES DERIVATIVES Merck Serono S.A. (CH) 2010-11-17 EP disclosed
WO-2009080663-A1 TRIAZOLE OXADIAZOLES DERIVATIVES MERCK SERONO S.A. (CH) 2009-07-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305092-A1 TRIAZOLE OXADIAZOLES DERIVATIVES OXA1L, RO60, PDCD11 ALDH1A1 466/4885NPSR1 1081/4885CYP1A2 543/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.